Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Montreal Immune-Related Adverse Events (MIRAE) Study

for
Cancer, Immune System Disorder, Inflammatory Reaction,
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital

Sex: All

Age: 18 - 70+

Code: NCT05139706

Recruiting

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

for
Solid Tumors, Non Small Cell Lung Cancer,
Location: New Haven CT
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT06205706

Phase 1, Phase 2, Recruiting

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

for
Cancer, Period Problem
Location: Commack NY, Rockville Centre NY, East White Plains NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 15 - 40

Code: NCT06915116

Phase 2, Recruiting

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Location: Boston MA, Providence RI, Mineola NY, New York NY,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT05836324

Phase 1, Recruiting

Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning

for
Malignant Solid Neoplasm,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic

Sex: All

Age: 0+

Code: NCT06200116

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Cisplatin Induced Kidney Toxicity

for
Acute Kidney Injury, Cancer
Location: London
Sponsor: The Hospital for Sick Children

Sex: All

Age: 0+

Code: NCT04442516

Recruiting

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

for
Advanced EGFR Positive Solid Tumor
Location: The Bronx NY, Fairway KS, Los Angeles CA
Sponsor: Changchun Intellicrown Pharmaceutical Co. LTD

Sex: All

Age: 18+

Code: NCT04412616

Phase 1, Recruiting

Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

for
Breast Cancer
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: Female

Age: 18+

Code: NCT04022616

Recruiting

Massage Impact on Sleep in Pediatric Oncology

for
Cancer, Pediatric Cancer, Chemotherapy Effect,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 12 - 21

Code: NCT06892158

Recruiting

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

for
Educational Materials for Genetic Testing, Breast Cancer,
Location: Jamaica NY, Richmond Hill NY, Brooklyn NY, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT04751435

Recruiting

MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)

for
Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT04358913

Recruiting

A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)

for
Breast Cancer, HER2-positive
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT05035836

Phase 2, Recruiting

A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies

for
Cancer
Location: Saint John, Montreal, Ottawa, Toronto, Hamilton,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT03847649

Phase 2, Recruiting

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for
Advanced Cancer
Location: New York NY, Newark DE, Baltimore MD, Bethesda MD,
Sponsor: Riboscience, LLC.

Sex: All

Age: 18+

Code: NCT05270213

Phase 1, Recruiting

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

for
Neoplasms, Arteriovenous Malformation of Central Nervous System,
Location: Miami FL, Detroit MI
Sponsor: The Radiosurgery Society

Sex: All

Age: 0+

Code: NCT01885299

Recruiting

Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy

for
Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III,
Location: Knoxville TN
Sponsor: Thompson Cancer Survival Center

Sex: Female

Age: 18+

Code: NCT06006806

Recruiting

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Baltimore MD, Whittier CA, Los Angeles CA
Sponsor: Zhejiang Haichang Biotech Co., Ltd.

Sex: All

Age: 18+

Code: NCT05267899

Phase 1, Recruiting

Kadcyla And Neratinib for Interception of HER2+ Breast Cancer With Molecular Residual Disease

for
Breast Cancer, HER2-positive Breast Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05388149

Phase 2, Recruiting

Active Living After Cancer: Implementation Within Be Well Acres Homes

for
Cancer, Fatigue
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06907706

Recruiting

HP Pyruvate MRI in Cancers

for
Image, Warburg Effect, Tumors
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT05697406

Phase 1, Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial